Postoperative oral chemoprophylaxis in patients undergoing hip arthroscopy mitigates VTE risk with a low sideeffect profile
dc.citation.doi | 10.1093/JHPS/HNAA063 | |
dc.citation.epage | 532 | |
dc.citation.spage | 524 | |
dc.contributor.author | Wesley Verhoogt | |
dc.contributor.author | Jurek Pietrzak | |
dc.contributor.author | O Ayeni | |
dc.contributor.author | Josip Cakic | |
dc.date.accessioned | 2023-04-13T13:14:23Z | |
dc.date.available | 2023-04-13T13:14:23Z | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 2054-8397 | |
dc.identifier.uri | https://hdl.handle.net/10539/35108 | |
dc.journal.title | JOURNAL OF HIP PRESERVATION SURGERY | |
dc.journal.volume | 7 | |
dc.title | Postoperative oral chemoprophylaxis in patients undergoing hip arthroscopy mitigates VTE risk with a low sideeffect profile |
Files
Original bundle
1 - 1 of 1